{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:54:05Z","timestamp":1794282845161,"version":"4.9.0"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41401-026-01801-0","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:18:20Z","timestamp":1775683100000},"page":"2023-2034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gut microbiota and renal fibrosis: novel mechanistic insights and therapeutic potential"],"prefix":"10.1038","volume":"47","author":[{"given":"Li-min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-fei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-teng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"1801_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat Rev Nephrol. 2024;20:473\u201385.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR2","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i3.97214","volume":"13","author":"S Khandpur","year":"2024","unstructured":"Khandpur S, Mishra P, Mishra S, Tiwari S. Challenges in predictive modelling of chronic kidney disease: a narrative review. World J Nephrol. 2024;13:97214.","journal-title":"World J Nephrol"},{"key":"1801_CR3","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.7150\/ijbs.111238","volume":"21","author":"H Ding","year":"2025","unstructured":"Ding H, Zhou Y, Zhu RH, Yu S, Zhang AQ, Liu H, et al. HIF-1-mediated macrophage metabolic reprogramming promotes AKI to CKD transition. Int J Biol Sci. 2025;21:5936\u201355.","journal-title":"Int J Biol Sci"},{"key":"1801_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41581-024-00875-5","volume":"20","author":"K Lee","year":"2024","unstructured":"Lee K, Jang HR, Rabb H. Lymphocytes and innate immune cells in acute kidney injury and repair. Nat Rev Nephrol. 2024;20:789\u2013805.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR5","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.7150\/ijbs.96812","volume":"20","author":"W Jiang","year":"2024","unstructured":"Jiang W, Tang TT, Zhang YL, Li ZL, Wen Y, Yang Q, et al. CD8 T cells induce the peritubular capillary rarefaction during AKI to CKD transition. Int J Biol Sci. 2024;20:2980\u201393.","journal-title":"Int J Biol Sci"},{"key":"1801_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41581-023-00796-9","volume":"20","author":"SJ Glastras","year":"2024","unstructured":"Glastras SJ, Pollock CA. Targeted identification of risk and treatment of diabetic kidney disease. Nat Rev Nephrol. 2024;20:75\u20136.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR7","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","volume":"103","author":"S Rayego-Mateos","year":"2023","unstructured":"Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fern\u00e1ndez C, Marchant V, Donate-Correa J, et al. Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2023;103:282\u201396.","journal-title":"Kidney Int"},{"key":"1801_CR8","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa2210639","volume":"387","author":"S Bhandari","year":"2022","unstructured":"Bhandari S, Mehta S, Khwaja A, Cleland JGF, Ives N, Brettell E, et al. Renin-angiotensin system inhibition in advanced chronic kidney disease. N Engl J Med. 2022;387:2021\u201332.","journal-title":"N Engl J Med"},{"key":"1801_CR9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41581-024-00918-x","volume":"21","author":"R Agarwal","year":"2025","unstructured":"Agarwal R, Verma A, Georgianos PI. Diuretics in patients with chronic kidney disease. Nat Rev Nephrol. 2025;21:264\u201378.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR10","doi-asserted-by":"crossref","unstructured":"Walther CP, Winkelmayer WC, Richardson PA, Virani SS, Navaneethan SD. Renin-angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease. Nephrol Dial Transpl. 2021;36:1893\u20139.","DOI":"10.1093\/ndt\/gfaa300"},{"key":"1801_CR11","doi-asserted-by":"crossref","unstructured":"Urushihara M, Kagami S. Role of the intrarenal renin-angiotensin system in the progression of renal disease. Pediatr Nephrol. 2016;32:1471\u20139.","DOI":"10.1007\/s00467-016-3449-7"},{"key":"1801_CR12","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i3.95739","volume":"13","author":"EA Shdaifat","year":"2024","unstructured":"Shdaifat EA, Abu-Sneineh FT, Ibrahim AM. Quality of life and psychological distress in end-stage renal disease patients undergoing hemodialysis and transplantation. World J Nephrol. 2024;13:95739.","journal-title":"World J Nephrol"},{"key":"1801_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41581-023-00782-1","volume":"20","author":"R Correa-Rotter","year":"2024","unstructured":"Correa-Rotter R, Maple-Brown LJ, Sahay R, Tuttle KR, Ulasi II. New and emerging therapies for diabetic kidney disease. Nat Rev Nephrol. 2024;20:156\u201360.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR14","doi-asserted-by":"crossref","unstructured":"Acquah-Mills J, Henneh IT, Arhin SM, Ekor M. The prevalence, pattern of use and impact of traditional, complementary and alternative medicine (TCAM) among patients with end stage renal disease undergoing haemodialysis at a tertiary health facility in Ghana. Clin Tradit Med Pharmacol. 2025;6:200232.","DOI":"10.1016\/j.ctmp.2025.200232"},{"key":"1801_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41581-025-00960-3","volume":"21","author":"CW McIntyre","year":"2025","unstructured":"McIntyre CW, Jain A. Dialysis and cognitive impairment. Nat Rev Nephrol. 2025;21:553\u201364.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR16","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i1.89637","volume":"13","author":"VD Raikou","year":"2024","unstructured":"Raikou VD. Renoprotective strategies. World J Nephrol. 2024;13:89637.","journal-title":"World J Nephrol"},{"key":"1801_CR17","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i4.100268","volume":"13","author":"G Araji","year":"2024","unstructured":"Araji G, Keesari PR, Chowdhry V, Valsechi-Diaz J, Afif S, Diab W, et al. Vitamin B12 deficiency in dialysis patients: risk factors, diagnosis, complications, and treatment: a comprehensive review. World J Nephrol. 2024;13:100268.","journal-title":"World J Nephrol"},{"key":"1801_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","volume":"21","author":"L Abbad","year":"2025","unstructured":"Abbad L, Esteve E, Chatziantoniou C. Advances and challenges in kidney fibrosis therapeutics. Nat Rev Nephrol. 2025;21:314\u201329.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR19","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i2.95410","volume":"13","author":"P Balakumar","year":"2024","unstructured":"Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: the intricate connection with multifaceted mechanism. World J Nephrol. 2024;13:95410.","journal-title":"World J Nephrol"},{"key":"1801_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41581-024-00914-1","volume":"21","author":"AM Hall","year":"2025","unstructured":"Hall AM. Protein handling in kidney tubules. Nat Rev Nephrol. 2025;21:241\u201352.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR21","doi-asserted-by":"crossref","unstructured":"Li J, Xiang T, Zhang F, Feng L, Wu Y, Guo F, et al. Tubular ACSM3 deficiency impairs medium-chain fatty acid metabolism and aggravates kidney fibrosis. Proc Natl Acad Sci USA. 2025;122:e2505752122.","DOI":"10.1073\/pnas.2505752122"},{"key":"1801_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41581-024-00902-5","volume":"21","author":"V De Gregorio","year":"2025","unstructured":"De Gregorio V, Barua M, Lennon R. Collagen formation, function and role in kidney disease. Nat Rev Nephrol. 2025;21:200\u201315.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR23","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00027","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu Y. Kidney fibrosis: fundamental questions, challenges, and perspectives. Integr Med Nephrol Androl. 2024;11:e24\u201300027.","journal-title":"Integr Med Nephrol Androl"},{"key":"1801_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41581-025-00969-8","volume":"21","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang Y, Liu Y. Fibroblast activation and heterogeneity in fibrotic disease. Nat Rev Nephrol. 2025;21:613\u201332.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR25","doi-asserted-by":"crossref","unstructured":"Miao H, Wang YN, Su W, Zou L, Zhuang SG, Yu XY, et al. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway. Acta Pharmacol Sin. 2023;45:137\u201349.","DOI":"10.1038\/s41401-023-01148-w"},{"key":"1801_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","volume":"17","author":"RA DeFronzo","year":"2021","unstructured":"DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol. 2021;17:319\u201334.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","volume":"207","author":"YN Wang","year":"2023","unstructured":"Wang YN, Miao H, Yu XY, Guo Y, Su W, Liu F, et al. Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy. Free Radic Biol Med. 2023;207:89\u2013106.","journal-title":"Free Radic Biol Med"},{"key":"1801_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7150\/ijbs.87820","volume":"20","author":"H He","year":"2024","unstructured":"He H, Wang H, Chen X, Zhong Y, Huang XR, Ma RC, et al. Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling. Int J Biol Sci. 2024;20:200\u201317.","journal-title":"Int J Biol Sci"},{"key":"1801_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","volume":"20","author":"S Kishi","year":"2024","unstructured":"Kishi S, Nagasu H, Kidokoro K, Kashihara N. Oxidative stress and the role of redox signalling in chronic kidney disease. Nat Rev Nephrol. 2024;20:101\u201319.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR30","doi-asserted-by":"publisher","first-page":"750","DOI":"10.7150\/ijbs.125140","volume":"22","author":"Y Jin","year":"2026","unstructured":"Jin Y, Zhang SJ, Zhuang S, Li P, Miao H, Zhao YY. Microbiota-gut-kidney axis in health and renal disease. Int J Biol Sci. 2026;22:750\u201370.","journal-title":"Int J Biol Sci"},{"key":"1801_CR31","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.3390\/ijms232314838","volume":"23","author":"P Paul","year":"2022","unstructured":"Paul P, Kaul R, Chaari A. Renal health improvement in diabetes through microbiome modulation of the gut-kidney axis with biotics: a systematic and narrative review of randomized controlled trials. Int J Mol Sci. 2022;23:14838.","journal-title":"Int J Mol Sci"},{"key":"1801_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","volume":"9","author":"H Miao","year":"2024","unstructured":"Miao H, Liu F, Wang YN, Yu XY, Zhuang S, Guo Y, et al. Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal Transduct Target Ther. 2024;9:195.","journal-title":"Signal Transduct Target Ther"},{"key":"1801_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114830","volume":"43","author":"ZL Si","year":"2024","unstructured":"Si ZL, Wang HY, Wang T, Cao YZ, Li QZ, Liu K, et al. Gut Bacteroides ovatus ameliorates renal fibrosis by promoting the production of HDCA through upregulation of Clostridium scindens. Cell Rep. 2024;43:114830.","journal-title":"Cell Rep"},{"key":"1801_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33824-6","volume":"13","author":"W Zhou","year":"2022","unstructured":"Zhou W, Wu WH, Si ZL, Liu HL, Wang H, Jiang H, et al. The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice. Nat Commun. 2022;13:6081.","journal-title":"Nat Commun"},{"key":"1801_CR35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.cmet.2021.06.014","volume":"33","author":"H Zhu","year":"2021","unstructured":"Zhu H, Cao C, Wu Z, Zhang H, Sun Z, Wang M, et al. The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease. Cell Metab. 2021;33:1926\u201342.e8.","journal-title":"Cell Metab"},{"key":"1801_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19:77\u201394.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR37","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/IMNA-D-25-00026","volume":"12","author":"X He","year":"2025","unstructured":"He X, Guo Y, Zhao Y. Targeting gut microbiota as a promising therapy for chronic kidney disease. Integr Med Nephrol Androl. 2025;12:e25\u201300026.","journal-title":"Integr Med Nephrol Androl"},{"key":"1801_CR38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","volume":"22","author":"FC Ross","year":"2024","unstructured":"Ross FC, Patangia D, Grimaud G, Lavelle A, Dempsey EM, Ross RP, et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat Rev Microbiol. 2024;22:671\u201386.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR39","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.7150\/ijbs.85259","volume":"19","author":"Y Gong","year":"2023","unstructured":"Gong Y, Chen A, Zhang G, Shen Q, Zou L, Li J, et al. Cracking brain diseases from gut microbes-mediated metabolites for precise treatment. Int J Biol Sci. 2023;19:2974\u201398.","journal-title":"Int J Biol Sci"},{"key":"1801_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:135.","journal-title":"Signal Transduct Target Ther"},{"key":"1801_CR41","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.7150\/ijbs.79430","volume":"19","author":"JA Shim","year":"2023","unstructured":"Shim JA, Ryu JH, Jo Y, Hong C. The role of gut microbiota in T cell immunity and immune mediated disorders. Int J Biol Sci. 2023;19:1178\u201391.","journal-title":"Int J Biol Sci"},{"key":"1801_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","volume":"81","author":"XJ Li","year":"2024","unstructured":"Li XJ, Shan QY, Wu X, Miao H, Zhao YY. Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis. Cell Mol Life Sci. 2024;81:480.","journal-title":"Cell Mol Life Sci"},{"key":"1801_CR43","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.7150\/ijbs.115359","volume":"21","author":"H Miao","year":"2025","unstructured":"Miao H, Zhang SJ, Wu X, Li P, Zhao YY. Tryptophan metabolism as a target in gut microbiota, ageing and kidney disease. Int J Biol Sci. 2025;21:4374\u201387.","journal-title":"Int J Biol Sci"},{"key":"1801_CR44","doi-asserted-by":"crossref","unstructured":"Zheng L, Luo M, Zhou H, Chen J. Natural products from plants and microorganisms: novel therapeutics for chronic kidney disease via gut microbiota regulation. Front Pharmacol. 2022;13:1068613.","DOI":"10.3389\/fphar.2022.1068613"},{"key":"1801_CR45","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41575-025-01077-5","volume":"22","author":"Y Sanz","year":"2025","unstructured":"Sanz Y, Cryan JF, Deschasaux-Tanguy M, Elinav E, Lambrecht R, Veiga P. The gut microbiome connects nutrition and human health. Nat Rev Gastroenterol Hepatol. 2025;22:534\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1801_CR46","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41579-024-01107-0","volume":"23","author":"R Joos","year":"2025","unstructured":"Joos R, Boucher K, Lavelle A, Arumugam M, Blaser MJ, Claesson MJ, et al. Examining the healthy human microbiome concept. Nat Rev Microbiol. 2025;23:192\u2013205.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41579-022-00850-6","volume":"21","author":"K Serrano","year":"2023","unstructured":"Serrano K, Bezrutcyzk M. Genome to gut: crop engineering for human microbiomes. Nat Rev Microbiol. 2023;21:132.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41579-025-01183-w","volume":"23","author":"I Mukhopadhya","year":"2025","unstructured":"Mukhopadhya I, Louis P. Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat Rev Microbiol. 2025;23:635\u201351.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR49","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41579-025-01166-x","volume":"23","author":"V Heidrich","year":"2025","unstructured":"Heidrich V, Valles-Colomer M, Segata N. Human microbiome acquisition and transmission. Nat Rev Microbiol. 2025;23:568\u201384.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR50","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21:719\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR51","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.7150\/ijbs.91771","volume":"20","author":"X Yu","year":"2024","unstructured":"Yu X, Li W, Li Z, Wu Q, Sun S. Influence of microbiota on tumor immunotherapy. Int J Biol Sci. 2024;20:2264\u201394.","journal-title":"Int J Biol Sci"},{"key":"1801_CR52","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41579-024-01077-3","volume":"22","author":"JA Gilbert","year":"2024","unstructured":"Gilbert JA, Hartmann EM. The indoors microbiome and human health. Nat Rev Microbiol. 2024;22:742\u201355.","journal-title":"Nat Rev Microbiol"},{"key":"1801_CR53","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.7150\/ijbs.82362","volume":"19","author":"J Wang","year":"2023","unstructured":"Wang J, Zhou T, Liu F, Huang Y, Xiao Z, Qian Y, et al. Influence of gut microbiota on resilience and its possible mechanisms. Int J Biol Sci. 2023;19:2588\u201398.","journal-title":"Int J Biol Sci"},{"key":"1801_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-022-00647-z","volume":"19","author":"H Krukowski","year":"2023","unstructured":"Krukowski H, Valkenburg S, Madella AM, Garssen J, van Bergenhenegouwen J, Overbeek SA, et al. Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential. Nat Rev Nephrol. 2023;19:87\u2013101.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR55","doi-asserted-by":"crossref","unstructured":"Yu M, Li L, Ren Q, Feng H, Tao S, Cheng L, et al. Understanding the gut-kidney axis in antineutrophil cytoplasmic antibody-associated vasculitis: an analysis of gut microbiota composition. Front Pharmacol. 2022;13:783679.","DOI":"10.3389\/fphar.2022.783679"},{"key":"1801_CR56","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020;69:2131\u201342.","journal-title":"Gut"},{"key":"1801_CR57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41581-023-00758-1","volume":"20","author":"A Zarbock","year":"2024","unstructured":"Zarbock A, Forni LG, Ostermann M, Ronco C, Bagshaw SM, Mehta RL, et al. Designing acute kidney injury clinical trials. Nat Rev Nephrol. 2024;20:137\u201346.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR58","doi-asserted-by":"crossref","unstructured":"Zong C, Xu GL, Ning M, Li JY, Wang X, Guo HJ, et al. PU.1\/Spi1 exacerbates ischemia-reperfusion induced acute kidney injury via upregulating Gata2 and promoting fibroblast activation. Acta Pharmacol Sin. 2025;46:2251\u201366.","DOI":"10.1038\/s41401-025-01530-w"},{"key":"1801_CR59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41581-022-00539-2","volume":"18","author":"Hukriede","year":"2022","unstructured":"Hukriede, Soranno DE NA, Sander V, Perreau T, Starr MC, Yuen PST, et al. Experimental models of acute kidney injury for translational research. Nat Rev Nephrol. 2022;18:277\u201393.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103373","volume":"77","author":"XX Zhu","year":"2024","unstructured":"Zhu XX, Fu X, Meng XY, Su JB, Zheng GL, Xu AJ, et al. Gut microbiome and metabolites mediate the benefits of caloric restriction in mice after acute kidney injury. Redox Biol. 2024;77:103373.","journal-title":"Redox Biol"},{"key":"1801_CR61","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00592-019-01316-7","volume":"56","author":"S Tao","year":"2019","unstructured":"Tao S, Li L, Li L, Liu Y, Ren Q, Shi M, et al. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition. Acta Diabetol. 2019;56:581\u201392.","journal-title":"Acta Diabetol"},{"key":"1801_CR62","doi-asserted-by":"crossref","unstructured":"Miao H, Zhang YM, Yu XY, Zou L, Zhao YY. Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy. Front Pharmacol. 2022;13:969930.","DOI":"10.3389\/fphar.2022.969930"},{"key":"1801_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202201581","volume":"9","author":"J Shang","year":"2022","unstructured":"Shang J, Zhang Y, Guo R, Liu W, Zhang J, Yan G, et al. Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy. Adv Sci (Weinh). 2022;9:e2201581.","journal-title":"Adv Sci (Weinh)"},{"key":"1801_CR64","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000533537","volume":"54","author":"X Shi","year":"2023","unstructured":"Shi X, Li Z, Lin W, Shi W, Hu R, Chen G, et al. Altered intestinal microbial flora and metabolism in patients with idiopathic membranous nephropathy. Am J Nephrol. 2023;54:451\u201370.","journal-title":"Am J Nephrol"},{"key":"1801_CR65","doi-asserted-by":"crossref","unstructured":"Miao H, Wang YN, Yu XY, Zou L, Guo Y, Su W, et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. Br J Pharmacol. 2024;181:162\u201379.","DOI":"10.1111\/bph.16219"},{"key":"1801_CR66","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","volume":"92","author":"E Mishima","year":"2017","unstructured":"Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int. 2017;92:634\u201345.","journal-title":"Kidney Int"},{"key":"1801_CR67","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/cvr\/cvac121","volume":"119","author":"EG Avery","year":"2023","unstructured":"Avery EG, Bartolomaeus H, Rauch A, Chen CY, N\u2019Diaye G, L\u00f6ber U, et al. Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage. Cardiovasc Res. 2023;119:1441\u201352.","journal-title":"Cardiovasc Res"},{"key":"1801_CR68","doi-asserted-by":"publisher","first-page":"F1457","DOI":"10.1152\/ajprenal.90769.2008","volume":"297","author":"HR Jang","year":"2009","unstructured":"Jang HR, Gandolfo MT, Ko GJ, Satpute S, Racusen L, Rabb H. Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury. Am J Physiol Ren Physiol. 2009;297:F1457\u201365.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1801_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1450931","volume":"11","author":"L Peng","year":"2024","unstructured":"Peng L, Chen X, Wang Z, Yi L, Jin Z. Maternal puerperal infection caused by Parabacteroides goldsteinii: a case report. Front Med. 2024;11:1450931.","journal-title":"Front Med"},{"key":"1801_CR70","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2291164","volume":"15","author":"SJ Gavzy","year":"2023","unstructured":"Gavzy SJ, Kensiski A, Lee ZL, Mongodin EF, Ma B, Bromberg JS. Bifidobacterium mechanisms of immune modulation and tolerance. Gut Microbes. 2023;15:2291164.","journal-title":"Gut Microbes"},{"key":"1801_CR71","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1039\/D4FO02014F","volume":"15","author":"Y Meng","year":"2024","unstructured":"Meng Y, Zhao M, Ma Q, Hua Q, Hu J, Zhou Q, et al. Bifidobacterium bifidum alleviates adenine-induced acute kidney injury in mice by improving intestinal barrier function. Food Funct. 2024;15:8030\u201342.","journal-title":"Food Funct"},{"key":"1801_CR72","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.7150\/ijbs.103977","volume":"20","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhou Y, Yu B, Deng Y, Wang Y, Fang S, et al. Multi-omics approaches to discover biomarkers of thyroid eye disease: a systematic review. Int J Biol Sci. 2024;20:6038\u201355.","journal-title":"Int J Biol Sci"},{"key":"1801_CR73","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41581-025-01007-3","volume":"22","author":"K Sharma","year":"2025","unstructured":"Sharma K, Hansen J, Susztak K, Eberlin L, Anderton CR, Alexandrov T, et al. Spatial metabolomics and multiomics integration for breakthroughs in precision medicine for kidney disease. Nat Rev Nephrol. 2025;22:152\u201364.","journal-title":"Nat Rev Nephrol"},{"key":"1801_CR74","doi-asserted-by":"crossref","unstructured":"Li XJ, Fang C, Zhao RH, Zou L, Miao H, Zhao YY. Bile acid metabolism in health and ageing-related diseases. Biochem Pharmacol. 2024;225:116313.","DOI":"10.1016\/j.bcp.2024.116313"},{"key":"1801_CR75","doi-asserted-by":"crossref","unstructured":"Li XJ, Suo P, Wang YN, Zou L, Nie XL, Zhao YY, et al. Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition. Front Pharmacol. 2024;15:1365802.","DOI":"10.3389\/fphar.2024.1365802"},{"key":"1801_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101861","volume":"85","author":"HJ Liu","year":"2023","unstructured":"Liu HJ, Miao H, Yang JZ, Liu F, Cao G, Zhao YY. Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis. Ageing Res Rev. 2023;85:101861.","journal-title":"Ageing Res Rev"},{"key":"1801_CR77","doi-asserted-by":"crossref","unstructured":"Cao G, Miao H, Wang YN, Chen DQ, Wu XQ, Chen L, et al. Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice. Acta Pharmacol Sin. 2022;43:2929\u201345.","DOI":"10.1038\/s41401-022-00914-6"},{"key":"1801_CR78","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.7150\/ijbs.98362","volume":"20","author":"S Chen","year":"2024","unstructured":"Chen S, Zeng Q, Cai X, Xue J, Yin G, Song P, et al. Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy. Int J Biol Sci. 2024;20:4438\u201357.","journal-title":"Int J Biol Sci"},{"key":"1801_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102013","volume":"90","author":"R Gupta","year":"2023","unstructured":"Gupta R, Kumari S, Senapati A, Ambasta RK, Kumar P. New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson\u2019s disease. Ageing Res Rev. 2023;90:102013.","journal-title":"Ageing Res Rev"},{"key":"1801_CR80","doi-asserted-by":"crossref","unstructured":"Miao H, Cao G, Wu XQ, Chen YY, Chen DQ, Chen L, et al. Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation. Br J Pharmacol. 2020;177:3415\u201335.","DOI":"10.1111\/bph.15062"},{"key":"1801_CR81","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00002","volume":"11","author":"V Corradi","year":"2024","unstructured":"Corradi V, Caprara C, Barzon E, Mattarollo C, Zanetti F, Ferrari F, et al. A possible role of p-cresyl sulfate and indoxyl sulfate as biomarkers in the prediction of renal function according to the GFR (G) categories. Integr Med Nephrol Androl. 2024;11:e24\u201300002.","journal-title":"Integr Med Nephrol Androl"},{"key":"1801_CR82","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1016\/j.apsb.2023.05.021","volume":"13","author":"H Pang","year":"2023","unstructured":"Pang H, Hu Z. Metabolomics in drug research and development: The recent advances in technologies and applications. Acta Pharm Sin B. 2023;13:3238\u201351.","journal-title":"Acta Pharm Sin B"},{"key":"1801_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103460","volume":"28","author":"A Palermo","year":"2023","unstructured":"Palermo A. Metabolomics- and systems-biology-guided discovery of metabolite lead compounds and druggable targets. Drug Discov Today. 2023;28:103460.","journal-title":"Drug Discov Today"},{"key":"1801_CR84","doi-asserted-by":"crossref","unstructured":"Wang YN, Zhang ZH, Liu HJ, Guo ZY, Zou L, Zhang YM, et al. Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease. Acta Pharmacol Sin. 2023;44:393\u2013405.","DOI":"10.1038\/s41401-022-00947-x"},{"key":"1801_CR85","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41589-023-01526-9","volume":"20","author":"GD D\u2019Agostino","year":"2024","unstructured":"D\u2019Agostino GD, Chaudhari SN, Devlin AS. Host-microbiome orchestration of the sulfated metabolome. Nat Chem Biol. 2024;20:410\u201321.","journal-title":"Nat Chem Biol"},{"key":"1801_CR86","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.7150\/ijbs.93075","volume":"20","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Lin XH, Guo HY, Shi X, Zhang DY, Sun JL, et al. Multi-omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. Int J Biol Sci. 2024;20:2763\u201378.","journal-title":"Int J Biol Sci"},{"key":"1801_CR87","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathol-020117-043559","volume":"15","author":"W Van Treuren","year":"2020","unstructured":"Van Treuren W, Dodd D. Microbial contribution to the human metabolome: implications for health and disease. Annu Rev Pathol. 2020;15:345\u201369.","journal-title":"Annu Rev Pathol"},{"key":"1801_CR88","doi-asserted-by":"publisher","first-page":"5608","DOI":"10.7150\/ijbs.98107","volume":"20","author":"DL Boaru","year":"2024","unstructured":"Boaru DL, Fraile-Martinez O, De Leon-Oliva D, Garcia-Montero C, De Castro-Martinez P, Miranda-Gonzalez A, et al. Harnessing the anti-inflammatory properties of polyphenols in the treatment of inflammatory bowel disease. Int J Biol Sci. 2024;20:5608\u201372.","journal-title":"Int J Biol Sci"},{"key":"1801_CR89","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41573-025-01211-7","volume":"24","author":"A Elkrief","year":"2025","unstructured":"Elkrief A, Pidgeon R, Maleki Vareki S, Messaoudene M, Castagner B, Routy B. The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development. Nat Rev Drug Discov. 2025;24:685\u2013704.","journal-title":"Nat Rev Drug Discov"},{"key":"1801_CR90","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tim.2022.08.003","volume":"31","author":"B Jia","year":"2023","unstructured":"Jia B, Zou Y, Han X, Bae JW, Jeon CO. Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease. Trends Microbiol. 2023;31:76\u201391.","journal-title":"Trends Microbiol"},{"key":"1801_CR91","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.chom.2024.07.017","volume":"32","author":"DP Baars","year":"2024","unstructured":"Baars DP, Fondevila MF, Meijnikman AS, Nieuwdorp M. The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes. Cell Host Microbe. 2024;32:1280\u2013300.","journal-title":"Cell Host Microbe"},{"key":"1801_CR92","doi-asserted-by":"publisher","first-page":"F487","DOI":"10.1152\/ajprenal.00092.2018","volume":"315","author":"LD Chaves","year":"2018","unstructured":"Chaves LD, McSkimming DI, Bryniarski MA, Honan AM, Abyad S, Thomas SA, et al. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. Am J Physiol Ren Physiol. 2018;315:F487\u2013502.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1801_CR93","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013;83:308\u201315.","journal-title":"Kidney Int"},{"key":"1801_CR94","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gutjnl-2024-334634","volume":"74","author":"M Laiola","year":"2025","unstructured":"Laiola M, Koppe L, Larabi A, Thirion F, Lange C, Quinquis B, et al. Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study. Gut. 2025;74:1624\u201337.","journal-title":"Gut"},{"key":"1801_CR95","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/ATVBAHA.120.314139","volume":"40","author":"N Gupta","year":"2020","unstructured":"Gupta N, Buffa JA, Roberts AB, Sangwan N, Skye SM, Li L, et al. Targeted inhibition of gut microbial trimethylamine N-oxide production reduces renal tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease. Arterioscler Thromb Vasc Biol. 2020;40:1239\u201355.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1801_CR96","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1681\/ASN.0000000000000344","volume":"35","author":"M Wang","year":"2024","unstructured":"Wang M, Tang WHW, Li XS, de Oliveira Otto MC, Lee Y, Lemaitre RN, et al. The gut microbial metabolite trimethylamine N-oxide, incident CKD, and kidney function decline. J Am Soc Nephrol. 2024;35:749\u201360.","journal-title":"J Am Soc Nephrol"},{"key":"1801_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39824-4","volume":"14","author":"P Andrikopoulos","year":"2023","unstructured":"Andrikopoulos P, Aron-Wisnewsky J, Chakaroun R, Myridakis A, Forslund SK, Nielsen T, et al. Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide. Nat Commun. 2023;14:5843.","journal-title":"Nat Commun"},{"key":"1801_CR98","doi-asserted-by":"crossref","unstructured":"Zhao BR, Hu XR, Wang WD, Zhou Y. Cardiorenal syndrome: clinical diagnosis, molecular mechanisms and therapeutic strategies. Acta Pharmacol Sin. 2025;46:1539\u201355.","DOI":"10.1038\/s41401-025-01476-z"},{"key":"1801_CR99","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","volume":"97","author":"T Gryp","year":"2020","unstructured":"Gryp T, De Paepe K, Vanholder R, Kerckhof FM, Van Biesen W, Van de Wiele T, et al. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Kidney Int. 2020;97:1230\u201342.","journal-title":"Kidney Int"},{"key":"1801_CR100","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.kint.2024.01.040","volume":"105","author":"J Lee","year":"2024","unstructured":"Lee J, Lee J, Kim K, Lee J, Jung Y, Hyeon JS, et al. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition. Kidney Int. 2024;105:1239\u201353.","journal-title":"Kidney Int"},{"key":"1801_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2025.111784","volume":"421","author":"H Liu","year":"2025","unstructured":"Liu H, Xiang X, Shi C, Guo J, Ran T, Lin J, et al. Oxidative stress and inflammation in renal fibrosis: novel molecular mechanisms and therapeutic targets. Chem Biol Interact. 2025;421:111784.","journal-title":"Chem Biol Interact"},{"key":"1801_CR102","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/ndt\/gfae082","volume":"39","author":"Y Ren","year":"2024","unstructured":"Ren Y, Wang Z, You L, Zhou J, Huang H, Chang S, et al. Gut-derived trimethylamine N-oxide promotes CCR2-mediated macrophage infiltration in acute kidney injury. Nephrol Dial Transpl. 2024;39:1876\u201389.","journal-title":"Nephrol Dial Transpl"},{"key":"1801_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2023.140192","volume":"342","author":"B Godfrey","year":"2023","unstructured":"Godfrey B, Li B, Gottshall E, Brysons S, Abrahamson B, Winkler M. Co-immobilization of AOA strains with anammox bacteria in three different synthetic bio-granules maintained under two substrate-level conditions. Chemosphere. 2023;342:140192.","journal-title":"Chemosphere"},{"key":"1801_CR104","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/toxins10090367","volume":"10","author":"WC Liu","year":"2018","unstructured":"Liu WC, Tomino Y, Lu KC. Impacts of indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120. Toxins. 2018;10:367.","journal-title":"Toxins"},{"key":"1801_CR105","doi-asserted-by":"crossref","unstructured":"Wang Q, Chen J, Chen H, Liang D, Zhou H, Chen J, et al. Indole-3-propionic acid exacerbates cisplatin-induced chronic kidney disease through the AHR\/NF-\u03baB signaling pathway. iScience. 2025;28:114149.","DOI":"10.1016\/j.isci.2025.114149"},{"key":"1801_CR106","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jare.2024.08.018","volume":"73","author":"Y Zeng","year":"2025","unstructured":"Zeng Y, Guo M, Wu Q, Tan X, Jiang C, Teng F, et al. Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1. J Adv Res. 2025;73:607\u201330.","journal-title":"J Adv Res"},{"key":"1801_CR107","doi-asserted-by":"publisher","DOI":"10.1177\/14703203251350803","volume":"26","author":"HB Yu","year":"2025","unstructured":"Yu HB, Qi L, Li HY, Su L, Bai Y, Liu YH, et al. Indolepropionic acid protects against renal fibrosis due to unilateral ureteral obstruction by enhancing the Nrf2 signaling pathway. J Renin-Angiotensin-Aldosterone Syst. 2025;26:14703203251350803.","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"key":"1801_CR108","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1038\/s41564-024-01831-6","volume":"9","author":"K Whelan","year":"2024","unstructured":"Whelan K, Alexander M, Gaiani C, Lunken G, Holmes A, Staudacher HM, et al. Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome. Nat Microbiol. 2024;9:2785\u201394.","journal-title":"Nat Microbiol"},{"key":"1801_CR109","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","volume":"76","author":"TA Ikizler","year":"2020","unstructured":"Ikizler TA, Burrowes JD, Byham-Gray LD, Campbell KL, Carrero JJ, Chan W, et al. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. Am J Kidney Dis. 2020;76:S1\u2013s107.","journal-title":"Am J Kidney Dis"},{"key":"1801_CR110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41575-024-00981-6","volume":"22","author":"R Hutkins","year":"2025","unstructured":"Hutkins R, Walter J, Gibson GR, Bedu-Ferrari C, Scott K, Tancredi DJ, et al. Classifying compounds as prebiotics - scientific perspectives and recommendations. Nat Rev Gastroenterol Hepatol. 2025;22:54\u201370.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1801_CR111","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-024-01023-x","volume":"22","author":"H Szajewska","year":"2025","unstructured":"Szajewska H, Scott KP, de Meij T, Forslund-Startceva SK, Knight R, Koren O, et al. Antibiotic-perturbed microbiota and the role of probiotics. Nat Rev Gastroenterol Hepatol. 2025;22:155\u201372.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1801_CR112","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.3390\/ijms23073658","volume":"23","author":"YT Chou","year":"2022","unstructured":"Chou YT, Kan WC, Shiao CC. Acute kidney injury and gut dysbiosis: a narrative review focus on pathophysiology and treatment. Int J Mol Sci. 2022;23:3658.","journal-title":"Int J Mol Sci"},{"key":"1801_CR113","doi-asserted-by":"publisher","first-page":"E120","DOI":"10.1161\/CIRCRESAHA.122.320184","volume":"131","author":"HB Li","year":"2022","unstructured":"Li HB, Xu ML, Xu XD, Tang YY, Jiang HL, Li L, et al. Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 axis. Circ Res. 2022;131:E120\u2013E34.","journal-title":"Circ Res"},{"key":"1801_CR114","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v13.i4.98719","volume":"13","author":"N Stepanova","year":"2024","unstructured":"Stepanova N. Probiotic interventions in peritoneal dialysis: a review of underlying mechanisms and therapeutic potentials. World J Nephrol. 2024;13:98719.","journal-title":"World J Nephrol"},{"key":"1801_CR115","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1007\/s42770-024-01491-y","volume":"55","author":"X Wang","year":"2024","unstructured":"Wang X, Shi M, Cao C, Zeng R, Yao Y. Effects of live and pasteurized forms of Lactobacillus casei Zhang on acute kidney injury and chronic renal fibrosis. Braz J Microbiol. 2024;55:3699\u2013709.","journal-title":"Braz J Microbiol"},{"key":"1801_CR116","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.clnu.2021.12.041","volume":"41","author":"A Podadera-Herreros","year":"2022","unstructured":"Podadera-Herreros A, Alcala-Diaz JF, Gutierrez-Mariscal FM, Jimenez-Torres J, Cruz-Ares S, Arenas-de Larriva AP, et al. Long-term consumption of a Mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: the CORDIOPREV randomized controlled trial. Clin Nutr. 2022;41:552\u20139.","journal-title":"Clin Nutr"},{"key":"1801_CR117","doi-asserted-by":"publisher","first-page":"13757","DOI":"10.1021\/acs.jafc.4c02591","volume":"72","author":"J Xia","year":"2024","unstructured":"Xia J, Zhang Y, Zhang S, Lu C, Huan H, Guan X. Oat dietary fiber delays the progression of chronic kidney disease in mice by modulating the gut microbiota and reducing uremic toxin levels. J Agric Food Chem. 2024;72:13757\u201368.","journal-title":"J Agric Food Chem"},{"key":"1801_CR118","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2305716","volume":"16","author":"B Speckmann","year":"2024","unstructured":"Speckmann B, Ehring E, Hu J, Rodriguez Mateos A. Exploring substrate-microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions. Gut Microbes. 2024;16:2305716.","journal-title":"Gut Microbes"},{"key":"1801_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2025.200239","volume":"6","author":"X Wu","year":"2025","unstructured":"Wu X, Sun W, Xing L, Zhao J. Effect of Yishenqinglihuoxue formula in the treatment of patients with stage 5 chronic kidney disease using propensity score matching: a retrospective clinical study. Clin Tradit Med Pharmacol. 2025;6:200239.","journal-title":"Clin Tradit Med Pharmacol"},{"key":"1801_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctmp.2025.200245","volume":"6","author":"X Gao","year":"2025","unstructured":"Gao X, Chen L, Zhang C, Gao H, Yang S, Huang G, et al. Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP\/NLRP3 signaling pathway. Clin Tradit Med Pharmacol. 2025;6:200245.","journal-title":"Clin Tradit Med Pharmacol"},{"key":"1801_CR121","doi-asserted-by":"publisher","first-page":"9457","DOI":"10.2147\/DDDT.S557114","volume":"19","author":"H Miao","year":"2025","unstructured":"Miao H, Wang KE, Li P, Zhao YY. Rhubarb: traditional uses, phytochemistry, multiomics-based novel pharmacological and toxicological mechanisms. Drug Des Dev Ther. 2025;19:9457\u201380.","journal-title":"Drug Des Dev Ther"},{"key":"1801_CR122","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.2147\/DDDT.S521265","volume":"19","author":"HY Feng","year":"2025","unstructured":"Feng HY, Wang YQ, Yang J, Miao H, Zhao YY, Li X. Anthraquinones from Rheum officinale ameliorate renal fibrosis in acute kidney injury and chronic kidney disease. Drug Des Dev Ther. 2025;19:5739\u201360.","journal-title":"Drug Des Dev Ther"},{"key":"1801_CR123","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2506810","volume":"47","author":"C Li","year":"2025","unstructured":"Li C, Chen X, Zha W, Fang S, Shen J, Li L, et al. Impact of gut microbiota in chronic kidney disease: natural polyphenols as beneficial regulators. Ren Fail. 2025;47:2506810.","journal-title":"Ren Fail"},{"key":"1801_CR124","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1038\/s41401-025-01598-4","volume":"46","author":"YN Wang","year":"2025","unstructured":"Wang YN, Wu X, Shan QY, Yang Q, Yu XY, Yang JH, et al. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacol Sin. 2025;46:2975\u201388.","journal-title":"Acta Pharmacol Sin"},{"key":"1801_CR125","doi-asserted-by":"crossref","unstructured":"Ajibade TO, Oliyide EO, Esan OO, Adetona MO, Awoyomi OV, Oyagbemi TO, et al. Protective effects of naringin on fipronil-induced cardiovascular and renal dysfunctions in rats. Clin Tradit Med Pharmacol. 2024;5:200138.","DOI":"10.1016\/j.ctmp.2024.200138"},{"key":"1801_CR126","doi-asserted-by":"crossref","unstructured":"Li XJ, Wang YN, Wang WF, Nie X, Miao H, Zhao YY. Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation. Front Pharmacol. 2024;15:1386604.","DOI":"10.3389\/fphar.2024.1386604"},{"key":"1801_CR127","doi-asserted-by":"crossref","unstructured":"Liang BE, Long LS, Wu XY, Huang MY, Lai Y, Yuan X, et al. Alginate oligosaccharide prevents renal ischemia-reperfusion injury in rats via MRC1-mediated pathway. Acta Pharmacol Sin. 2025;46:2450\u201367.","DOI":"10.1038\/s41401-025-01545-3"},{"key":"1801_CR128","doi-asserted-by":"crossref","unstructured":"Wang B, Yang LN, Yang LT, Liang Y, Guo F, Fu P, et al. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis. Acta Pharmacol Sin. 2024;45:150\u201365.","DOI":"10.1038\/s41401-023-01156-w"},{"key":"1801_CR129","doi-asserted-by":"crossref","unstructured":"Ben-Azu B, Asiwe JN, Oritsemuelebi B, Chidebe EO, Onuelu JE, Isibor H, et al. Morin inhibits oxidative stress and inflammation in the cardiorenal system associated with post-traumatic stress and alcohol use disorders in mice. Clin Tradit Med Pharmacol. 2025;6:200196.","DOI":"10.1016\/j.ctmp.2025.200196"},{"key":"1801_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154129","volume":"101","author":"B Xu","year":"2022","unstructured":"Xu B, Zheng J, Tian X, Yuan F, Liu Z, Zhou Y, et al. Protective mechanism of traditional Chinese medicine guizhi fuling pills against carbon tetrachloride-induced kidney damage is through inhibiting oxidative stress, inflammation and regulating the intestinal flora. Phytomedicine. 2022;101:154129.","journal-title":"Phytomedicine"},{"key":"1801_CR131","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/IMNA-D-25-00017","volume":"12","author":"H Miao","year":"2025","unstructured":"Miao H, Vaziri ND. Hederagenin: molecular mechanisms and therapeutic potential for chronic kidney disease. Integr Med Nephrol Androl. 2025;12:e25\u201300017.","journal-title":"Integr Med Nephrol Androl"},{"key":"1801_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154913","volume":"117","author":"S Ma","year":"2023","unstructured":"Ma S, Zhao M, Chang M, Shi X, Shi Y, Zhang Y. Effects and mechanisms of Chinese herbal medicine on IgA nephropathy. Phytomedicine. 2023;117:154913.","journal-title":"Phytomedicine"},{"key":"1801_CR133","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/13880209.2024.2345080","volume":"62","author":"X Dong","year":"2024","unstructured":"Dong X, Zhang J, Li W, Li Y, Jia L, Liu Z, et al. Yi-Shen-Hua-Shi regulates intestinal microbiota dysbiosis and protects against proteinuria in patients with chronic kidney disease: a randomized controlled study. Pharm Biol. 2024;62:356\u201366.","journal-title":"Pharm Biol"},{"key":"1801_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153561","volume":"86","author":"W Lin","year":"2021","unstructured":"Lin W, Jiang C, Yu H, Wang L, Li J, Liu X, et al. The effects of Fushen granule on the composition and function of the gut microbiota during peritoneal dialysis-related peritonitis. Phytomedicine. 2021;86:153561.","journal-title":"Phytomedicine"},{"key":"1801_CR135","doi-asserted-by":"publisher","first-page":"528","DOI":"10.34067\/KID.0006792020","volume":"2","author":"S Noel","year":"2021","unstructured":"Noel S, Mohammad F, White J, Lee K, Gharaie S, Rabb H. Gut microbiota-immune system interactions during acute kidney injury. Kidney360. 2021;2:528\u201331.","journal-title":"Kidney360"},{"key":"1801_CR136","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1681\/ASN.2014030288","volume":"26","author":"V Andrade-Oliveira","year":"2015","unstructured":"Andrade-Oliveira V, Amano MT, Correa-Costa M, Castoldi A, Felizardo RJ, de Almeida DC, et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol. 2015;26:1877\u201388.","journal-title":"J Am Soc Nephrol"},{"key":"1801_CR137","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.97957","volume":"3","author":"Y Nakade","year":"2018","unstructured":"Nakade Y, Iwata Y, Furuichi K, Mita M, Hamase K, Konno R, et al. Gut microbiota-derived D-serine protects against acute kidney injury. JCI Insight. 2018;3:e97957.","journal-title":"JCI Insight"},{"key":"1801_CR138","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod. 2020;83:770\u2013803.","journal-title":"J Nat Prod"},{"key":"1801_CR139","doi-asserted-by":"crossref","unstructured":"Guo ZY, Wu X, Zhang SJ, Yang JH, Miao H, Zhao YY. Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology. Acta Pharmacol Sin. 2025;46:836\u201351.","DOI":"10.1038\/s41401-024-01404-7"},{"key":"1801_CR140","doi-asserted-by":"crossref","unstructured":"Wang YN, Li XJ, Wang WF, Zou L, Miao H, Zhao YY. Geniposidic acid attenuates chronic tubulointerstitial nephropathy through regulation of the NF-\u03baB\/Nrf2 pathway via aryl hydrocarbon receptor signaling. Phytother Res. 2024;38:5441\u201357.","DOI":"10.1002\/ptr.8324"},{"key":"1801_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156128","volume":"135","author":"X Yang","year":"2024","unstructured":"Yang X, Xin Y, Gu Y, Wang Y, Hu X, Ying G, et al. Total alkaloids of Aconitum carmichaelii Debx alleviate cisplatin-induced acute renal injury by inhibiting inflammation and oxidative stress related to gut microbiota metabolism. Phytomedicine. 2024;135:156128.","journal-title":"Phytomedicine"},{"key":"1801_CR142","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.apsb.2022.12.010","volume":"13","author":"L Pan","year":"2023","unstructured":"Pan L, Yu H, Fu J, Hu J, Xu H, Zhang Z, et al. Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota. Acta Pharm Sin B. 2023;13:1537\u201353.","journal-title":"Acta Pharm Sin B"},{"key":"1801_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120994","volume":"358","author":"Z Lu","year":"2026","unstructured":"Lu Z, Li Z, Gu S, Cai Y, Wu Y, Huang L, et al. Exploring the gut-kidney axis: Berberine\u2019s role in alleviating chronic kidney disease through microbiota and short-chain fatty acids. J Ethnopharmacol. 2026;358:120994.","journal-title":"J Ethnopharmacol"},{"key":"1801_CR144","doi-asserted-by":"crossref","unstructured":"Jin M, Seed RI, Cai G, Shing T, Wang L, Ito S, et al. Dynamic allostery drives autocrine and paracrine TGF-\u03b2 signaling. Cell. 2024;187:6200\u201319.e23.","DOI":"10.1016\/j.cell.2024.08.036"},{"key":"1801_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1823800","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li J, Chen C, Lu J, Yu J, Xu X, et al. Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production. Gut Microbes. 2020;12:1\u201319.","journal-title":"Gut Microbes"},{"key":"1801_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.tifs.2024.104677","volume":"152","author":"RZ Huang","year":"2024","unstructured":"Huang RZ, Zhang J, Xu XX, Sun MZ, Xu LG, Kuang H, et al. The multiple benefits of bioactive polysaccharides: From the gut to overall health. Trends Food Sci Tech. 2024;152:104677.","journal-title":"Trends Food Sci Tech"},{"key":"1801_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138526","volume":"290","author":"Y Tu","year":"2025","unstructured":"Tu Y, Tang E, Ye H, Xiang Q, Ye Z, Hao Y, et al. Flammulina Velutipes polysaccharides ameliorate cisplatin-induced acute kidney injury in mice via regulation of gut microbiota and Ferroptosis pathway. Int J Biol Macromol. 2025;290:138526.","journal-title":"Int J Biol Macromol"},{"key":"1801_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138629","volume":"289","author":"Q Fu","year":"2025","unstructured":"Fu Q, Yang Y, Tian Q, Zhu Y, Xu H, Wang J, et al. Exploring the mechanism of Paotianxiong polysaccharide in the treatment of chronic kidney disease combining metabolomics and microbiomics technologies. Int J Biol Macromol. 2025;289:138629.","journal-title":"Int J Biol Macromol"},{"key":"1801_CR149","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ijbiomac.2022.03.077","volume":"206","author":"M Zhang","year":"2022","unstructured":"Zhang M, Yang L, Zhu M, Yang B, Yang Y, Jia X, et al. Moutan cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats. Int J Biol Macromol. 2022;206:849\u201360.","journal-title":"Int J Biol Macromol"},{"key":"1801_CR150","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.7150\/ijbs.114907","volume":"21","author":"L Feng","year":"2025","unstructured":"Feng L, Feng YY, Ren Q, Fu P, Ma L. Mesangial cells in diabetic kidney disease: from mechanisms to therapeutic implications. Int J Biol Sci. 2025;21:4762\u201381.","journal-title":"Int J Biol Sci"},{"key":"1801_CR151","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.7150\/ijbs.112737","volume":"21","author":"H Zhao","year":"2025","unstructured":"Zhao H, Guo J. Macrophages in focus: key drivers and therapeutic opportunities in diabetic kidney disease. Int J Biol Sci. 2025;21:4647\u201362.","journal-title":"Int J Biol Sci"},{"key":"1801_CR152","doi-asserted-by":"crossref","unstructured":"Yang TT, Shao YT, Cheng Q, He YT, Qiu Z, Pan DD, et al. YY1\/HIF-1\u03b1\/mROS positive-feedback loop exacerbates glomerular mesangial cell proliferation in mouse early diabetic kidney disease. Acta Pharmacol Sin. 2025;46:1974\u201389.","DOI":"10.1038\/s41401-025-01498-7"},{"key":"1801_CR153","doi-asserted-by":"crossref","unstructured":"Li XQ, Jin B, Liu SX, Zhu Y, Li N, Zhang QY, et al. Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic nephropathy. Acta Pharmacol Sin. 2025;46:1692\u2013705.","DOI":"10.1038\/s41401-024-01460-z"},{"key":"1801_CR154","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/IMNA-D-23-00029","volume":"11","author":"D Liu","year":"2024","unstructured":"Liu D, Chen X, He W, Lu M, Li Q, Zhang S, et al. Update on the pathogenesis, diagnosis, and treatment of diabetic tubulopathy. Integr Med Nephrol Androl. 2024;11:e23\u201300029.","journal-title":"Integr Med Nephrol Androl"},{"key":"1801_CR155","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3390\/ijms26041470","volume":"26","author":"G Xu","year":"2025","unstructured":"Xu G, Yuan H, Liu J, Wang X, Ma L, Wang Y, et al. Astragalus mongholicus polysaccharides alleviate kidney injury in rats with type 2 diabetes through modulation of oxidation, inflammation, and gut microbiota. Int J Mol Sci. 2025;26:1470.","journal-title":"Int J Mol Sci"},{"key":"1801_CR156","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13659-025-00566-z","volume":"16","author":"M Mei","year":"2026","unstructured":"Mei M, Sun H, Zhang K, Zhang F, Sun S, Zhang Y. Phellodendron amurense Rupr. Polysaccharides protects against diabetic nephropathy via alteration of PI3K\/GSK-3\u03b2\/Nrf2\/TGF-\u03b2\/Smad signaling pathway and gut microbiota. Nat Prod Bioprospect. 2026;16:13.","journal-title":"Nat Prod Bioprospect"},{"key":"1801_CR157","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molmed.2023.12.005","volume":"30","author":"CM Andary","year":"2024","unstructured":"Andary CM, Al KF, Chmiel JA, Gibbons S, Daisley BA, Parvathy SN, et al. Dissecting mechanisms of fecal microbiota transplantation efficacy in disease. Trends Mol Med. 2024;30:209\u201322.","journal-title":"Trends Mol Med"},{"key":"1801_CR158","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.cmet.2021.05.005","volume":"33","author":"NMJ Hanssen","year":"2021","unstructured":"Hanssen NMJ, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? Cell Metab. 2021;33:1098\u2013110.","journal-title":"Cell Metab"},{"key":"1801_CR159","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.chom.2023.03.019","volume":"31","author":"A Yadegar","year":"2023","unstructured":"Yadegar A, Pakpoor S, Ibrahim FF, Nabavi-Rad A, Cook L, Walter J, et al. Beneficial effects of fecal microbiota transplantation in recurrent clostridioides difficile infection. Cell Host Microbe. 2023;31:695\u2013711.","journal-title":"Cell Host Microbe"},{"key":"1801_CR160","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.kint.2023.03.024","volume":"104","author":"S Gharaie","year":"2023","unstructured":"Gharaie S, Lee K, Newman-Rivera AM, Xu J, Patel SK, Gooya M, et al. Microbiome modulation after severe acute kidney injury accelerates functional recovery and decreases kidney fibrosis. Kidney Int. 2023;104:470\u201391.","journal-title":"Kidney Int"},{"key":"1801_CR161","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/nu16081109","volume":"16","author":"GY Arteaga-Muller","year":"2024","unstructured":"Arteaga-Muller GY, Flores-Trevi\u00f1o S, Bocanegra-Ibarias P, Robles-Espino D, Garza-Gonz\u00e1lez E, Fabela-Valdez GC, et al. Changes in the progression of chronic kidney disease in patients undergoing fecal microbiota transplantation. Nutrients. 2024;16:1109.","journal-title":"Nutrients"},{"key":"1801_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-025-00705-4","volume":"17","author":"J Hu","year":"2025","unstructured":"Hu J, Liu D, Liao G, Guo Y, Li M, Liao J, et al. Fecal microbiota transplantation alleviates immunosuppressant-associated diarrhea and recurrent urinary tract infection in kidney transplant recipients: a retrospective analysis. Gut Pathog. 2025;17:28.","journal-title":"Gut Pathog"},{"key":"1801_CR163","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2174\/0113816128333694240928161703","volume":"31","author":"S Chauhan","year":"2025","unstructured":"Chauhan S, Bhandari U, Habib A. Insights into the novel biomarkers expressed in diabetic nephropathy: potential clinical applications. Curr Pharm Des. 2025;31:619\u201329.","journal-title":"Curr Pharm Des"},{"key":"1801_CR164","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3390\/toxins14030176","volume":"14","author":"S Lohia","year":"2022","unstructured":"Lohia S, Vlahou A, Zoidakis J. Microbiome in chronic kidney disease (CKD): an omics perspective. Toxins. 2022;14:176.","journal-title":"Toxins"},{"key":"1801_CR165","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ajt.13881","volume":"17","author":"SV Bontha","year":"2017","unstructured":"Bontha SV, Maluf DG, Mueller TF, Mas VR. Systems biology in kidney transplantation: the application of multi-omics to a complex model. Am J Transpl. 2017;17:11\u201321.","journal-title":"Am J Transpl"},{"key":"1801_CR166","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49212-1","volume":"15","author":"K Siew","year":"2024","unstructured":"Siew K, Nestler KA, Nelson C, D\u2019Ambrosio V, Zhong C, Li Z, et al. Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction. Nat Commun. 2024;15:4923.","journal-title":"Nat Commun"},{"key":"1801_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157496","volume":"148","author":"CH Jiang","year":"2025","unstructured":"Jiang CH, Zhang SJ, Li P, Miao H, Zhao YY. Natural products targeting TGF-\u03b2\/Smad signaling in renal fibrosis: Multiomics-based novel molecular mechanisms and therapeutic strategies. Phytomedicine. 2025;148:157496.","journal-title":"Phytomedicine"},{"key":"1801_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155499","volume":"128","author":"Y Wu","year":"2024","unstructured":"Wu Y, Mo J, Liang J, Pu X, Dong Y, Zhu X, et al. Multiomic study of the protective mechanism of Persicaria capitata (Buch.-Ham. ex D.Don) H.Gross against streptozotocin-induced diabetic nephropathy in Guizhou miniature pigs. Phytomedicine. 2024;128:155499.","journal-title":"Phytomedicine"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01801-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01801-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01801-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:02:54Z","timestamp":1788998574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01801-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":168,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01801-0","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}